Harbour Investments’s Agilon Health AGL Stock Holding History

Harbour Investments’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$1.37K	–	3129
2023 Q3	$1.37K	Buy	+3	New	+$1.35K	﹤0.01%	2636

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harbour Investments's AGL Position: Q4 2023 in Review

Harbour Investments sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 3 shares — an estimated $1.37K sold.

Harbour Investments first reported a position in AGL in Q3 2023 and held it in 1 quarter. The position peaked at $1.37K in Q3 2023. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

Harbour Investments reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
Harbour Investments sold 3 Agilon Health shares in Q4 2023, an estimated $1.37K.
Harbour Investments first reported a position in Agilon Health in Q3 2023 and held it in 1 quarter.
Harbour Investments's Agilon Health position peaked at $1.37K in Q3 2023.
193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Harbour Investments's 13F filing for Q4 2023, filed 16 Feb 2024.